171 related articles for article (PubMed ID: 23546688)
1. Therapeutic potential of SIGIRR in systemic lupus erythematosus.
Wang C; Feng CC; Pan HF; Wang DG; Ye DQ
Rheumatol Int; 2013 Aug; 33(8):1917-21. PubMed ID: 23546688
[TBL] [Abstract][Full Text] [Related]
2. The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity.
Wang DY; Su C; Chen GM; Pan HF; Wang FM; Liu GL; Hao L; Wang DG; Ye DQ
Mol Biol Rep; 2015 Feb; 42(2):423-30. PubMed ID: 25287661
[TBL] [Abstract][Full Text] [Related]
3. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
[TBL] [Abstract][Full Text] [Related]
4. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
5. The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.
Zhu YY; Su Y; Li ZG; Zhang Y
PLoS One; 2012; 7(8):e44131. PubMed ID: 22952899
[TBL] [Abstract][Full Text] [Related]
6. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.
Lech M; Kulkarni OP; Pfeiffer S; Savarese E; Krug A; Garlanda C; Mantovani A; Anders HJ
J Exp Med; 2008 Aug; 205(8):1879-88. PubMed ID: 18644972
[TBL] [Abstract][Full Text] [Related]
7. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.
Wald D; Qin J; Zhao Z; Qian Y; Naramura M; Tian L; Towne J; Sims JE; Stark GR; Li X
Nat Immunol; 2003 Sep; 4(9):920-7. PubMed ID: 12925853
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus.
Li J; Pan HF; Cen H; Tian J; Ma Y; Tao JH; Ye DQ
Mol Biol Rep; 2011 Aug; 38(6):4077-81. PubMed ID: 21107711
[TBL] [Abstract][Full Text] [Related]
9. SIGIRR deficiency contributes to CD4 T cell abnormalities by facilitating the IL1/C/EBPβ/TNF-α signaling axis in rheumatoid arthritis.
Teng X; Mou DC; Li HF; Jiao L; Wu SS; Pi JK; Wang Y; Zhu ML; Tang M; Liu Y
Mol Med; 2022 Nov; 28(1):135. PubMed ID: 36401167
[TBL] [Abstract][Full Text] [Related]
10. SIGIRR Negatively Regulates IL-36-Driven Psoriasiform Inflammation and Neutrophil Infiltration in the Skin.
Giannoudaki E; Stefanska AM; Lawler H; Leon G; Hernandez Santana YE; Hassan N; Russell SE; Horan R; Sweeney C; Preston RS; Mantovani A; Garlanda C; Fallon PG; Walsh PT
J Immunol; 2021 Jul; 207(2):651-660. PubMed ID: 34253575
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily.
Thomassen E; Renshaw BR; Sims JE
Cytokine; 1999 Jun; 11(6):389-99. PubMed ID: 10346978
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice.
Costello DA; Watson MB; Cowley TR; Murphy N; Murphy Royal C; Garlanda C; Lynch MA
J Neurosci; 2011 Mar; 31(10):3871-9. PubMed ID: 21389242
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
[TBL] [Abstract][Full Text] [Related]
14. SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens.
Sham HP; Yu EY; Gulen MF; Bhinder G; Stahl M; Chan JM; Brewster L; Morampudi V; Gibson DL; Hughes MR; McNagny KM; Li X; Vallance BA
PLoS Pathog; 2013; 9(8):e1003539. PubMed ID: 23950714
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.
Kadota C; Ishihara S; Aziz MM; Rumi MA; Oshima N; Mishima Y; Moriyama I; Yuki T; Amano Y; Kinoshita Y
Clin Exp Immunol; 2010 Nov; 162(2):348-61. PubMed ID: 21077278
[TBL] [Abstract][Full Text] [Related]
16. SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells.
Li D; Zhang X; Chen B
BMC Immunol; 2015 Dec; 16():73. PubMed ID: 26634342
[TBL] [Abstract][Full Text] [Related]
17. α-TLR2 antibody attenuates the Aβ-mediated inflammatory response in microglia through enhanced expression of SIGIRR.
Costello DA; Carney DG; Lynch MA
Brain Behav Immun; 2015 May; 46():70-9. PubMed ID: 25620736
[TBL] [Abstract][Full Text] [Related]
18. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
19. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.
Bulek K; Swaidani S; Qin J; Lu Y; Gulen MF; Herjan T; Min B; Kastelein RA; Aronica M; Kosz-Vnenchak M; Li X
J Immunol; 2009 Mar; 182(5):2601-9. PubMed ID: 19234154
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor associated kinase 1 is a potential therapeutic target of anti-inflammatory therapy for systemic lupus erythematosus.
Li M; Yu D; Ni B; Hao F
Mol Immunol; 2017 Jul; 87():94-101. PubMed ID: 28431280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
